| 000 | 01843 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517190831.0 | ||
| 264 | 0 | _c20180618 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1099-0461 | ||
| 024 | 7 |
_a10.1002/jbt.22017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKurdi, Amani | |
| 245 | 0 | 0 |
_aNootkatone confers hepatoprotective and anti-fibrotic actions in a murine model of liver fibrosis by suppressing oxidative stress, inflammation, and apoptosis. _h[electronic resource] |
| 260 |
_bJournal of biochemical and molecular toxicology _cFeb 2018 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntioxidants _xadministration & dosage |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCarbon Tetrachloride Poisoning _xphysiopathology |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xmetabolism |
| 650 | 0 | 4 |
_aCytokines _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDNA Fragmentation _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aHepatitis _xetiology |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aNitrosative Stress _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aPolycyclic Sesquiterpenes |
| 650 | 0 | 4 |
_aProtective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aSesquiterpenes _xtherapeutic use |
| 700 | 1 | _aHassan, Kamal | |
| 700 | 1 | _aVenkataraman, Balaji | |
| 700 | 1 | _aRajesh, Mohanraj | |
| 773 | 0 |
_tJournal of biochemical and molecular toxicology _gvol. 32 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jbt.22017 _zAvailable from publisher's website |
| 999 |
_c27863648 _d27863648 |
||